Primo Nutraceuticals BUGVF Stock
Primo Nutraceuticals Price Chart
Primo Nutraceuticals BUGVF Financial and Trading Overview
| Primo Nutraceuticals stock price | 0.0000 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 3 USD |
| Avg. Volume | 0 USD |
| Market Cap | 10 USD |
| Beta (5Y Monthly) | 2.66466 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.59 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BUGVF Valuation Measures
| Enterprise Value | 455.99K USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.7857143E-5 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Primo Nutraceuticals Stock Price History
| Beta (5Y Monthly) | 2.66466 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
BUGVF Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 10.09M |
| Float | 9.43M |
| Short Ratio | N/A |
| % Held by Insiders | 2.58% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:15 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | July 31, 2019 |
| Most Recent Quarter (mrq) | April 30, 2020 |
| Next Fiscal Year End | July 31, 2020 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -35.65% |
| Return on Equity (ttm) | -1082.37% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -5395613 USD |
| Diluted EPS (ttm) | -0.58 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 9.95K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 465.93K USD |
| Total Debt/Equity (mrq) | 83.01 USD |
| Current Ratio (mrq) | 0.012 |
| Book Value Per Share (mrq) | 0.056 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1411668 USD |
| Levered Free Cash Flow (ttm) | -476106 USD |
Profile of Primo Nutraceuticals
| Country | United States |
| State | BC |
| City | Vancouver |
| Address | 890 West Pender Street |
| ZIP | V6C 1J9 |
| Phone | 877-517-7816 |
| Website | https://www.primonutraceuticals.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
Q&A For Primo Nutraceuticals Stock
What is a current BUGVF stock price?
Primo Nutraceuticals BUGVF stock price today per share is 0.0000 USD.
How to purchase Primo Nutraceuticals stock?
You can buy BUGVF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Primo Nutraceuticals?
The stock symbol or ticker of Primo Nutraceuticals is BUGVF.
Which industry does the Primo Nutraceuticals company belong to?
The Primo Nutraceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Primo Nutraceuticals have in circulation?
The max supply of Primo Nutraceuticals shares is 0.
What is Primo Nutraceuticals Price to Earnings Ratio (PE Ratio)?
Primo Nutraceuticals PE Ratio is now.
What was Primo Nutraceuticals earnings per share over the trailing 12 months (TTM)?
Primo Nutraceuticals EPS is -0.59 USD over the trailing 12 months.
Which sector does the Primo Nutraceuticals company belong to?
The Primo Nutraceuticals sector is Healthcare.